KPV (Lysine–Proline–Valine) is a synthetic tripeptide derived from the C-terminal region of the hormone α-MSH (alpha-melanocyte-stimulating hormone), known for its role in modulating inflammatory responses.
Unlike full-length α-MSH, KPV retains potent anti-inflammatory properties without significant melanogenic activity, making it highly valuable for targeted research applications.
Originally studied for its immunomodulatory effects, KPV has shown strong potential in reducing pro-inflammatory cytokine activity and supporting tissue repair processes in experimental models.
Researched Benefits:
- Facilitates investigation of anti-inflammatory signaling pathways
- Supports analysis of cytokine modulation (e.g., TNF-α, IL-6)
- Enables studies on gut inflammation and epithelial barrier function
- Useful for exploring immune response regulation without hormonal side effects
- Assists in modeling inflammatory skin and gastrointestinal conditions
Description
KPV (10mg) is a research-grade tripeptide utilized in inflammation, immunology, and tissue repair studies. Synthesized with high precision and purity, it ensures consistent and reliable outcomes in laboratory environments.
Key Features:
- Derived from α-MSH C-terminal fragment
- High-purity synthesis with strict quality control
- Batch-tested for reproducibility and consistency
- Lyophilized for enhanced stability and storage longevity
Applications:
- Investigates inflammatory pathways and immune modulation
- Explores gut health and intestinal inflammation models
- Supports research on skin repair and wound healing
- Examines cytokine suppression and cellular recovery mechanisms
KPV is widely recognized in research for its targeted anti-inflammatory effects, offering a focused approach to studying immune regulation and tissue healing without broader hormonal activity.
